GlassScriptPhysician profile
Alexander C Small
NPI 1255674347
$32,955.13
in general payments reported to CMS, 2019-2025
17 companies · $1,372 in 2025
The $1,372 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,155 · 2021: $2,161 · 2022: $7,282 · 2023: $3,647 · 2024: $17K · 2025: $1,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $5,550 · Honoraria: $1,223 · Education: $10.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,573.81 |
| Food and Beverage | $5,550.23 |
| Honoraria | $1,223.00 |
| Education | $10.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $16,678.11 | 2023-2025 | Porges Coloplast, Virtue, Coloplast Tfl Drive |
| Boston Scientific Corporation | $10,493.40 | 2020-2024 | Lithovue |
| Urogen Pharma, INC. | $1,928.94 | 2021-2024 | Jelmyto |
| Ambu A/S | $1,223.00 | 2023 | |
| Calyxo, INC. | $1,108.94 | 2024-2025 | Cvac Aspiration System |
| Ambu INC. | $301.56 | 2023-2024 | |
| Medtronic, INC. | $247.92 | 2025 | |
| Cook Medical LLC | $210.75 | 2023-2024 | Fiber Dust, Caesar, Litho 150 |
| Alnylam Pharmaceuticals INC. | $174.19 | 2024-2025 | Oxlumo, Givlaari |
| Olympus America INC. | $154.91 | 2020-2023 | Itind System |
| Edap Technomed INC | $138.00 | 2024 | |
| Angiodynamics, INC. | $132.23 | 2022 | |
| Astellas Pharma US INC | $43.16 | 2022 | |
| Blue Earth Diagnostics | $36.27 | 2022-2023 | |
| Ethicon US, LLC | $31.50 | 2024 | Echelon Flex |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $27.67 | 2024 | |
| Novo Nordisk INC | $24.58 | 2025 | Rivfloza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.